BioNano Genomics Inc Share Price Today: Live Updates & Key Insights

BioNano Genomics Inc share price today is $1.12, up 0%. The stock opened at $1.11 against the previous close of $1.11, with an intraday high of $1.135 and low of $1.105.

BioNano Genomics Inc Share Price Chart

BioNano Genomics Inc

us-stock
To Invest in {{usstockname}}
us-stock

BioNano Genomics Inc Share Price Performance

$1.12 0(0%) BNGO at 27 Jul 2026 02:14 PM Medical Instruments & Supplies
Lowest Today 1.105
Highest Today 1.135
Today’s Open 1.11
Prev. Close 1.11
52 Week High 5.50
52 Week Low 1.06
Day’s Range: Low 1.105 High 1.135
52-Week Range: Low 1.06 High 5.50
1 day return -
1 Week return -1.76
1 month return -3.47
3 month return -10.48
6 month return -27.68
1 year return -66.05
3 year return -81.06
5 year return -98.1
10 year return -

BioNano Genomics Inc Institutional Holdings

GSA Capital Partners LLP 3.19

Geode Capital Management, LLC 1.51

Fidelity Extended Market Index 1.02

Vanguard Institutional Extnd Mkt Idx Tr 0.74

Vanguard Group Inc 0.74

Carret & Company Inc 0.63

Vanguard Capital Management, LLC 0.61

Vanguard Fiduciary Trust Co 0.47

Renaissance Technologies Corp 0.44

PGIM US Micro Cap Quant Equity 0.25

Prudential Financial Inc 0.25

Northern Trust Corp 0.19

TWO SIGMA SECURITIES, LLC 0.16

Northern Trust Extended Eq Market Idx 0.13

NT Ext Equity Mkt Index Fund - Lending 0.13

Virtu Financial LLC 0.12

Spartan Extended Market Index Pool F 0.11

Engineers Gate Manager LP 0.11

Fidelity Series Total Market Index 0.10

NT Ext Equity Mkt Index Fund - NL 0.10

BlackRock Inc 0.09

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.07

Spartan Total Market Index Pool G 0.06

Advisor Group Holdings, Inc. 0.06

NT Ext Eq Mkt Idx Fd DC Lending Tier 5 0.05

Blackrock Extended Mkt Fund CF 0.03

Extended Equity Market Fund B 0.03

Extended Equity Market Fund E 0.03

BlackRock Extended Equity Market Fund K 0.03

Fidelity Total Market Index 0.03

T. Rowe Price U.S. Equities Tr 0.01

Group One Trading, LLC 0.01

Morgan Stanley - Brokerage Accounts 0.01

Extended Equity Market Fund M 0.00

SBI Securities Co Ltd 0.00

State St US Extended Mkt Indx NL Cl C 0.00

Vanguard Global Advisers, LLC 0.00

Wells Fargo & Co 0.00

SSgA U.S. Total Market Index Strategy 0.00

UBS Group AG 0.00

BioNano Genomics Inc Market Status

Strong Buy: 0

Buy: 2

Hold: 2

Sell: 0

Strong Sell: 0

BioNano Genomics Inc Fundamentals

Market Cap 12.74 M

PB Ratio 0.3461

PE Ratio 0.0

Enterprise Value 15.46 M

Total Assets 73.58 M

Volume 101110

BioNano Genomics Inc Company Financials

Annual Revenue FY23:33610000 33.6M, FY22:27802000 27.8M, FY21:17981000 18.0M, FY20:8502984 8.5M, FY19:10129508 10.1M

Annual Profit FY23:8933000 8.9M, FY22:5945000 5.9M, FY21:3874000 3.9M, FY20:2772847 2.8M, FY19:3361361 3.4M

Annual Net worth FY23:-227279000 -227.3M, FY22:-132596000 -132.6M, FY21:-72435000 -72.4M, FY20:-41135544 -41.1M, FY19:-29836118 -29.8M

Quarterly Revenue Q1/2026:6687000 6.7M, Q3/2025:7367000 7.4M, Q2/2025:6733000 6.7M, Q1/2025:6457000 6.5M, Q3/2024:6073000 6.1M

Quarterly Profit Q1/2026:3252000 3.3M, Q3/2025:3525000 3.5M, Q2/2025:3477000 3.5M, Q1/2025:2938000 2.9M, Q3/2024:-8446000 -8.4M

Quarterly Net worth Q1/2026:-8303000 -8.3M, Q3/2025:-8503000 -8.5M, Q2/2025:-6857000 -6.9M, Q1/2025:-3102000 -3.1M, Q3/2024:-44246000 -44.2M

About BioNano Genomics Inc & investment objective

Company Information Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants. It also provides Saphyr and Stratys systems, which are sample-to-result solutions for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr and Stratys instruments, which are single-molecule imagers; Saphyr Chip, a consumable that packages the nanochannel arrays for DNA linearization; Bionano Prep Kits and DNA labeling kits, which provide the reagents and protocols for extracting and labeling ultra-high molecular weight DNA; and Ionic purification system, which isolates and purifies nucleic acid molecules. In addition, the company offers Saphyr, Stratys, and Bionano compute servers; and VIA software, which offers one solution for solutions for cytogenetics and molecular genetics. Further, it provides testing and laboratory services comprising FirstStepDx PLUS, a chromosomal microarray for identifying an underlying genetic cause in individuals with autism spectrum disorder, developmental delay, and intellectual disability; Fragile X syndrome (FXS) testing services; NextStepDx PLUS, a exome sequencing test to identify genetic variants that are associated with disorders of childhood development; OGM-Dx HemeOne testing; OGM-Dx FSHD, a test for individuals suspected of having FSHD type 1; and OGM-Dx Postnatal Whole Genome SV and OGM-Dx Prenatal Whole Genome SV for comprehensive testing. Bionano Genomics, Inc. was founded in 2003 and is headquartered in San Diego, California.

Organisation Medical Instruments & Supplies

Employees 95

Industry Medical Instruments & Supplies

CEO Dr. Albert A. Luderer Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

BioNano Genomics Inc FAQs

What is the share price of BioNano Genomics Inc today?

The current share price of BioNano Genomics Inc is $1.12.

Can I buy BioNano Genomics Inc shares in India?

Yes, Indian investors can buy BioNano Genomics Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy BioNano Genomics Inc shares in India?

You can easily invest in BioNano Genomics Inc shares from India by:

Can I buy fractional shares of BioNano Genomics Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of BioNano Genomics Inc?

BioNano Genomics Inc has a market cap of $12.74 M.

In which sector does BioNano Genomics Inc belong?

BioNano Genomics Inc operates in the Medical Instruments & Supplies sector.

What documents are required to invest in BioNano Genomics Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of BioNano Genomics Inc?

The PE ratio of BioNano Genomics Inc is N/A and the PB ratio is 0.35.